Drug Type Biological products |
Synonyms- |
Target |
Mechanism PDGFB modulators(Platelet-derived growth factor subunit B modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization MangoGen Pharma, Inc.Startup |
Active Organization MangoGen Pharma, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic foot ulcer | Preclinical | CA | MangoGen Pharma, Inc.Startup | 26 Sep 2024 |